Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Arthritis Rheum. 2012 Jan;64(1):53–61. doi: 10.1002/art.33322

Table 1.

Criteria for inclusion in the study of noncardiac vascular disease in rheumatoid arthritis (RA) and non-RA subjects*

1. Hemorrhagic stroke Clinical diagnosis by neurologist + verified by CT/MRI or autopsy or cerebrospinal fluid analysis
2. Nonhemorrhagic stroke or nonspecified stroke Clinical diagnosis by neurologist + verified by CT/MRI or autopsy
3. Transient ischemic attack Clinical diagnosis by neurologist
4. Amaurosis fugax Clinical diagnosis
5. Aortic aneurysm Diameter increased >50% compared with normal values; diameter ≥3.0 cm in abdominal aorta (43); verified by ultrasound/CT or at autopsy
6. Renal artery stenosis Verified by ultrasound/renal scintigraphy/angiography; assumed clinically significant if detected
7. Peripheral artery disease or atherosclerosis obliterans Clinical diagnosis supported by documented vascular physical examination; ankle/brachial index <0.9 or angiography confirming disease, if performed
8. Arterial thromboembolism Clinical diagnosis supported by angiography or autopsy
9. Deep vein thrombosis Verified by phlebography/venography or ultrasound or autopsy
10. Pulmonary embolism Verified by angiography, CT angiography, scintigraphy, or autopsy
*

CT = computed tomography; MRI = magnetic resonance imaging